| Tag | Content |
|---|
EnhancerAtlas ID | HS019-03639 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr12:25249980-25252000 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr12:25251607-25251627 | ACACAAAACAAACACAAACA | + | 6.3 | | Stat4 | MA0518.1 | chr12:25251860-25251874 | CCTCTTCCTGGAAA | - | 6.08 | | TBX21 | MA0690.1 | chr12:25250635-25250645 | TTCACACCTT | - | 6.02 | | TBX2 | MA0688.1 | chr12:25250634-25250645 | TTTCACACCTT | - | 6.62 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_11544 | chr12:25245152-25256375 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 25250905 | 25251202 | | chr12 | 25251345 | 25251440 |
|
Enhancer Sequence | AACCTGTCTT CATTTCTCTA GTTAGAATGA AATTACAAAA AAGATTCACT TTTCCTGAGA 60
CTATGGATTT CTCACTTCTA GGAATAAGTT TTAAAAAATA CTTTTGTTGT ATAAGACATA 120
TGCGTTTAAT ACATATGTGT TTAATACAGA AAAAATGGAA TATACAAATA AAAAATGTTA 180
AAAAAATATA ATACGATCCA GTGACAATCA TAAAATTTTT GTGATATATT CTTCAAGATG 240
TATAGTGTTA TAATATAGTG TTTATAATCC CTTATATAGT GTTATAATCT GCTTTTTATT 300
CATCATACAA CATAGGTAAC TTTCTGTGTG ATATAATTAT ATACTCACAT GTCACCATTT 360
TATGGTATTC TACTGGTTGA GTAGATATAA ATTATTTAAC CAATTCCTTG TATTCAATCA 420
TTTCAGGATG TTTTTGGTAT TTTTCTGTTA TAAACAATGC TCCAGTAAAT ATCCTTGTAT 480
ATGCATCTGT GTGTATTTGT CCTTAGAGAA GTAGAATTCC AAAATTTCTT TGTGGGCAAA 540
CCTGGGGAGA TATGAATTTT TTAAATCTAT ACCTAAGCAG ACTTGTTAAA ATATATTTTC 600
TTAAGGAGAA ATTTAATTGT GGTAGTAATT TTAGTTTGAT CATTTGTTAT ATACTTTCAC 660
ACCTTAGTTC CTTTTTAACC CCTCACTAGA GAATACTGTT ATTCTTTGTT TCATTTTTAC 720
TAAAGTTATA TATGCACATA GTTTTTTAAA AGGTCAATCA GCTCTATAAG CCTTACTAAT 780
TTCCCGTGAT CCAGAGAAAC AACTTTCAAC TTTTTGTCTT ATTTGTTTTG TATTTGCATT 840
CACATTTTTC AATAACATGC TCATGCTGCC ATTTAGTGAT TTATTTTCAG TTTTAGGTAT 900
TATCTGTTGC TCTTCCACTA CGAAGACAAA TATTTAGTTC TTTTATCAAT CTCTGGCCCA 960
TCACACCTTT TCACTGTCCC TCAAGCTACT GTTGGCCATC CTGCTTTCCT GGCCAAGCTT 1020
ATACTCCACA GTTAAACATA GTTTTCACTA CCTTGCATGT CCCCTCATCA CTTACCCCTT 1080
TCTTGCTTTG TCTTACTCAT TTGGCGAATC TACAAGTAAA TCCGCTTCTC CACCTCTCAT 1140
GCCTGCATAG CTGGAAAATG TCACATTCCC ATGCTGACCT GTTTCTCTTT GAATTCATTA 1200
TCACAAACCT CAAGCGGGTC CTTGGGGCTT CCCCTCAATC ACCCTCCTTC TCTTTTAAAT 1260
ATCAATTTCC CACCCTTTCC TTTCTCCTCA AACCACTGTC ATGTCTTTCC CCATATTCTC 1320
TCTCAAACAC AGGTAATGAC TGCTTCCAAC CTCACTGAGG AAACTGGGAC AATCAAAGGA 1380
AACTGCCACA AAGCCTCCCA GCGTGTGAAT CCTTACACAC TCCCTTGCTC TTGTTCCTAA 1440
AGATGCGTTG TCTCTAACCC TATCCAAGGC CAGCCTTCCC CACTGTAGAT GGGAGCCTTC 1500
CCGACTAATT TACTCAGAGT CATGGGACCA AATTCTCCTG ACTTTTCTCC ATTTACATTT 1560
TCTCCACTCT ACTGAACCAT TTCTATCAGC ACACAAATAA TATGTTGTTT TCTAGATGGG 1620
AATAATAACA CAAAACAAAC ACAAACAAAA TAACTTTTTA TCCTTTCTTT TCTGGCCACC 1680
ACCCTGTTTC TCTGCTCCCA TTTACAGCAA ACCTCGACAG AATGGTACTC ACTGTGTTCA 1740
GTCTCCCTCC TCCCACGTTC TCTCCAACCC ACTCTGTATC AGCCTTTTGC TTCCACAAAG 1800
CAGATTTTTC CAAGGTCACT AGTGACCTCC ACATTACCAA ATTCAGTTTC TCAGTCCTCA 1860
TCTGGCATGG CTGATGTCTT CCTCTTCCTG GAAATGCTTT CCTCACTTAG CTTCCAGGCA 1920
CCATGTCCTC TAGCTTTTCT CTACATCACG GGCTGCTCCT TCTAGGCTTC CTGCAGTTCT 1980
ACCCCTTCTC CTGGACCTCT GAATATTGAA GAGCCCCAGG 2020
|
